This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vimalachandran, D. Articles by Costello, E. Search for Related Content PubMed PubMed Citation Articles by Vimalachandran, D. Articles by Costello, E.

High Nuclear S100A6 (Calcyclin) Is Significantly Associated with Poor Survival in Pancreatic Cancer Patients

¹ Division of Surgery and Oncology and ² Cancer Tissue Bank Research Centre, Department of Pathology, University of Liverpool; ³ Department of Pathology, Royal Liverpool University Hospital, Liverpool, United Kingdom; ⁴ Department of Pathology, University of Schleswig-Holstein, Kiel, Germany; and ⁵ Cancer Research UK Clinical Centre, Queen Mary's School of Medicine at Barts and The London, London, United Kingdom

Requests for reprints: Eithne Costello, Division of Surgery and Oncology, University of Liverpool, Royal University Hospital, Daubly Street, Liverpool, Merseyside, United Kingdom. Phone: 44-151-706-4178; E-mail: ecostell{at}liv.ac.uk.

Recent studies have reported elevated levels of S100A6 in pancreatic ductal adenocarcinoma cells. Here, we describe a detailed analysis of S100A6 expression in benign (n = 32), malignant (n = 60), and premalignant pancreatic ductal cells [96 pancreatic intraepithelial neoplasias (PanIN) from 46 patients]. S100A6 staining was more intense in malignant cells than in benign cells (P = 0.0001). In malignant cells, staining was higher in the nucleus than in the cytoplasm (P = 0.003). Univariate analysis revealed a significant decrease in survival time for patients with high levels of nuclear (P = 0.01) but not cytoplasmic (P = 0.20) S100A6. No evidence was found for an association between nuclear S100A6 expression and other variables, including gender, age at surgery, tumor size or grade, nodal metastases, resection margin, vascular invasion, perineural invasion, p53 or Smad4 levels (both linked to survival in previous studies), or the p65 subunit of nuclear factor-B (a potential regulator of S100A6). Although nodal metastases and resection margin involvement were also associated with poor survival (P = 0.06 in both cases), multivariate analysis suggests that nuclear S100A6 is a significant independent indicator of survival (P = 0.003). Whereas PanIN 1a lesions showed a general absence of S100A6 staining, there was a progressive increase in the proportion of positively stained PanINs with increasing PanIN grade. In particular, we observed an increase in the frequency and intensity of nuclear staining. Our results suggest that up-regulation of S100A6 is an early event in pancreatic cancer development and that elevated levels of nuclear S100A6 may affect clinical outcome.

This article has been cited by other articles:

				M. Ouaissi, I. Sielezneff, R. Silvestre, B. Sastre, J.-P. Bernard, J. S. Lafontaine, M. J. Payan, L. Dahan, N. Pirro, J. F. Seitz, et al. High Histone Deacetylase 7 (HDAC7) Expression Is Significantly Associated with Adenocarcinomas of the Pancreas Ann. Surg. Oncol., August 1, 2008; 15(8): 2318 - 2328. [Abstract] [Full Text] [PDF]

				L. M. Orre, M. Pernemalm, J. Lengqvist, R. Lewensohn, and J. Lehtio Up-regulation, Modification, and Translocation of S100A6 Induced by Exposure to Ionizing Radiation Revealed by Proteomics Profiling Mol. Cell. Proteomics, December 1, 2007; 6(12): 2122 - 2131. [Abstract] [Full Text] [PDF]

				H. J. Whiteman, M. E. Weeks, S. E. Dowen, S. Barry, J. F. Timms, N. R. Lemoine, and T. Crnogorac-Jurcevic The Role of S100P in the Invasion of Pancreatic Cancer Cells Is Mediated through Cytoskeletal Changes and Regulation of Cathepsin D Cancer Res., September 15, 2007; 67(18): 8633 - 8642. [Abstract] [Full Text] [PDF]

				K. Ohuchida, K. Mizumoto, J. Yu, H. Yamaguchi, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka S100A6 Is Increased in a Stepwise Manner during Pancreatic Carcinogenesis: Clinical Value of Expression Analysis in 98 Pancreatic Juice Samples Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 649 - 654. [Abstract] [Full Text] [PDF]

				C C Thompson, F J Ashcroft, S Patel, G Saraga, D Vimalachandran, W Prime, F Campbell, A Dodson, R E Jenkins, N R Lemoine, et al. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility Gut, January 1, 2007; 56(1): 95 - 106. [Abstract] [Full Text] [PDF]

				R. Frances, J. R. Tumang, and T. L. Rothstein Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells Int. Immunol., January 1, 2007; 19(1): 59 - 65. [Abstract] [Full Text] [PDF]

				E. Giovannetti, V. Mey, S. Nannizzi, G. Pasqualetti, M. Del Tacca, and R. Danesi Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer. Mol. Cancer Ther., June 1, 2006; 5(6): 1387 - 1395. [Abstract] [Full Text] [PDF]